Evidence map›Paper›PMID 29519811›Full record

Observational studyJournal of the American Heart Association2018

Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.

Cian P McCarthy, Nasrien E Ibrahim, Asya Lyass, Yiwei Li, Hanna K Gaggin, Mandy L Simon, Renata Mukai, Parul Gandhi, Noreen Kelly, Shweta R Motiwala and 4 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00842868 (The CASABLANCA Study), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00842868 completednot on this map

The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases. An Observational Biomarker Study

TypeobservationalSponsorMassachusetts General HospitalRan2008 to 2015Enrolled1,298ConditionsAtherosclerosis, Contrast Induced Nephropathy, Renal Impairment
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Increasingly Sensitive Troponin Assays: Is Perfect the Enemy of Good?Journal of the American Heart Association · 2020
    Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Cian P McCarthyDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Nasrien E IbrahimDivision of Cardiology, Massachusetts General Hospital, Boston, MA.
Asya LyassCardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA.
Yiwei LiCardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA.
Hanna K GagginDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Mandy L SimonDivision of Cardiology, Massachusetts General Hospital, Boston, MA.
Renata MukaiDivision of Cardiology, Massachusetts General Hospital, Boston, MA.
Parul GandhiDivision of Cardiology, VA Connecticut Healthcare System and Yale University, New Haven, CT.
Noreen KellyDivision of Cardiology, Brigham and Women's Hospital, Boston, MA.
Shweta R MotiwalaDivision of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA.
Roland R J van KimmenadeDivision of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Joseph M MassaroDepartment of Biostatistics, Boston University School of Public Health, Boston, MA.
Ralph B D'AgostinoCardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA.
James L JanuzziDepartment of Medicine, Massachusetts General Hospital, Boston, MA jjanuzzi@mgh.harvard.edu.
Massachusetts General Hospital · USBaim Institute for Clinical Research · USBeth Israel Deaconess Medical Center · USBoston University · USBrigham and Women's Hospital · USMaastricht University Medical Centre · NLYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe meaning of high-sensitivity troponin I (hsTnI) concentrations in patients without acute myocardial infarction (MI) requires clarity. We hypothesized that among patients referred for diagnostic coronary angiography without acute MI, hsTnI concentrations would correlate with prevalent coronary artery disease (CAD) and predict incident cardiovascular events and mortality. METHODS AND

resultsWe measured hsTnI using a single-molecule counting assay (99th percentile, 6 ng/L) in samples from 991 patients obtained at the time of angiography. Concentrations of hsTnI were assessed relative to the severity of CAD and prognosis during mean follow-up of 3.7 years. Median hsTnI concentration was 4.19 ng/L; 38% of patients had hsTnI concentrations ≥99th percentile. Across increasing hsTnI quartiles, patients had higher prevalence of angiographic CAD; in multivariate models, hsTnI ≥99th percentile independently predicted obstructive CAD (odds ratio: 2.57;

conclusionsIn a large prospective cohort of patients who were free of prevalent MI and undergoing diagnostic coronary angiography, hsTnI concentrations were associated with higher prevalence of CAD and predicted incident MI, cardiovascular death, and all-cause death. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00842868.

Indexed as

Coronary AngiographyAgedBiomarkersBostonCoronary Artery DiseaseCoronary StenosisDisease ProgressionFemaleHumansIncidenceMaleMiddle AgedPredictive Value of TestsPrevalencePrognosisProspective StudiesBiomarkersTroponin Ibiomarkerscoronary artery diseasehigh‐sensitivitytroponin

Identifiers

PMID29519811
PMCPMC5907559
OpenAlexW2791824125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.